IP Verse

Method For Preventing And/Or Treating Insulin Resistance - EP2753187

The patent EP2753187 was granted to Academisch Medisch Centrum on Aug 6, 2025. The application was originally filed on Aug 30, 2012 under application number EP12758652A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2753187

ACADEMISCH MEDISCH CENTRUM
Application Number
EP12758652A
Filing Date
Aug 30, 2012
Status
Patent Maintained As Amended
Jul 4, 2025
Grant Date
Aug 6, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANJul 15, 2019AVIDITYADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2011043654
INTERNATIONAL-SEARCH-REPORTEP1917869
INTERNATIONAL-SEARCH-REPORTUS6224863
INTERNATIONAL-SEARCH-REPORTUS6645530
INTERNATIONAL-SEARCH-REPORTWO2008076696
INTERNATIONAL-SEARCH-REPORTWO2010036876
INTERNATIONAL-SEARCH-REPORTWO2011145516
OPPOSITIONEP1523320
OPPOSITIONEP1838837
OPPOSITIONUS2007258953
OPPOSITIONWO2008076696
OPPOSITIONWO2009153662
OPPOSITIONWO2010108865
OPPOSITIONWO2011043654
OPPOSITIONWO2017116235

Non-Patent Literature (NPL) Citations (53) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AHANCHI ET AL., AM J PHYSIOL HEART CIRC PHYSIOL, (2008), vol. 295, pages H2388 - 98-
DESCRIPTION- ANDERSON ET AL., APPL ENVIRON MICROBIOL, (1993), vol. 95, pages 3525 - 33-
DESCRIPTION- ANNAMALAI ET AL., ANN MICROBIOL., (201112), vol. 61, no. 4, pages 801 - 807-
DESCRIPTION- ANTIMICROB. AGENTS CHEMOTHER., (1976), vol. 10, pages 926 - 928-
DESCRIPTION- BARCENILLA ET AL., APPL. ENVIRON. MICROBIOL., (200004), vol. 66, no. 4, pages 1654 - 61-
DESCRIPTION- BOOIJNK ET AL., ENV MICROBIOL, (2010), vol. 12, pages 3213 - 27-
DESCRIPTION- BREIMAN, "Bagging predictors", MACHINE LEARNING, (1996), vol. 24, no. 2-
DESCRIPTION- LANGEVELD ET AL., J CLIN ENDOCRINOL METAB, (2008), vol. 93, no. 3, pages 845 - 851-
DESCRIPTION- LANGEVELD, J CLIN ENDOCRINOL METAB, (2008), vol. 93, no. 3, pages 845 - 851-
DESCRIPTION- MUNOZ-TAMAYO ET AL., FEMS MICROBIOL ECOLO, (2011), vol. 76, pages 615 - 624-
DESCRIPTION- NADKARNI ET AL., MICROBIOLOGY 2002, (2002), vol. 148, pages 257 - 266-
DESCRIPTION- RAJILIC-STOJANIOVIC ET AL., ENVIRON. MICROBIOL., (2007), vol. 9, no. 9, pages 2125 - 2136-
DESCRIPTION- RAJILIC-STOJANOVIC, ENVIRON. MICROBIOL., (2009), vol. 11, no. 7, pages 1736 - 1751-
DESCRIPTION- WOLEVER ET AL., BR J NUTR, (2000), vol. 84, no. 1, pages 57 - 61-
DESCRIPTION- ZOETENDAL, SYST APPL MICROBIOL, (2001), vol. 24, no. 3, pages 405 - 410-
DESCRIPTION- STOREY J.A., "A direct approach to false discovery rates", JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B (STATISTICAL METHODOLOGY, (2010), vol. 64, no. 3, doi:doi:10.1111/1467-9868.00346, pages 479 - 498, XP055061495
OPPOSITION- Arvans et al, Am J Physiol Gastrointest Liver Physiol, 2005; 288:696-704-
OPPOSITION- Belenguer et al (Applied and Environmental Microbiology, May 2006,p. 3593-3599 Vol. 72, No.5)-
OPPOSITION- Bindels, L. B. et al. (2017) ‘Resistant starch can improve insulin sensitivity independently of the gut microbiota’, Microbiome. Microbiome, 5(1), pp. 1-16. doi: 10.1186/s40168-017-0230-5-
OPPOSITION- Bouter, KEC. et al, Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects. Clinical and Translational Gastroenterology, 2018; 9:155-
OPPOSITION- Darfeuille-Michaud et al, Gastroenterology, 2004; 127: 412-421-
OPPOSITION- Delzenne, N. M. et al. (2015) ‘Gut microorganisms as promising targets for the management of type 2 diabetes’, Diabetologia, 58(10), pp. 2206-2217. doi: 10.1007/s00125-015-3712-7-
OPPOSITION- Engels et al (2016)'Frontiers in Microbiology vol:7,article 713-
OPPOSITION- Gao, Z. et al Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009; 58:1509-1517-
OPPOSITION- Gilijamse, P.W., et al. Treatment with Anaerobutyricum soehngenii:metabolism in human subjects with metabolic syndrome, npj Biofilms Microbiomes 6, 16 (2020)-
OPPOSITION- Haro, C. et al. (2016) ‘Two healthy diets modulate gut microbial community improving insulin sensitivity in a human obese population’, Journal of Clinical Endocrinology and Metabolism,101(1), pp. 233-242. doi: 10.1210/jc.2015-3351-
OPPOSITION- Hempel (2011, Evidence Report/technology Assessment, 01 Apr 2011, (200):1 -645)-
OPPOSITION- Hippe et al, FEMS Microbiol. Lett., 2011; 316 (2): 103-135-
OPPOSITION- Hold et al, Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis, FEMS Microbiology Ecology 39 (2002) 33-39-
OPPOSITION- Houghton, D. et al. (2018) ‘Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes’, Diabetologia. Diabetologia, 61(8), pp. 1700-1711.doi: 10.1007/S00125-018-4632-0-
OPPOSITION- Koopen et al 2020-
OPPOSITION- Koopen et al (Gut. 2021 Oct 25:gutjnl-2020-323297-
OPPOSITION- Lupp et al, Cell Host & Microbe, 2007; 2 (2): 119-129-
OPPOSITION- Mondot et al, Inflammatory Bowel Diseases, 2011; 17 (1): 185-192-
OPPOSITION- Obata, T, et al, Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody- mediated symbiosis, PNAS, 2010; 107(16):7419-24-
OPPOSITION- Rajilic-Stojanovic et al, Environ. Microbiol., 2007, 9(9), 2125-2136-
OPPOSITION- Ramirez-Farias et ai (2009) British Journal of Nutrition-101:541-550-
OPPOSITION- Rossello-Mora & Amann, FEMS Microbiology Reviews 25 (2001) 39-67-
OPPOSITION- Sanz et al, Interdisciplinary Perspectives on Infectious Diseases,2008-
OPPOSITION- Sheridan et al, Microbial Genomics, 2016, Feb 9; 2 (2): e000043-
OPPOSITION- Shetty et al, Int. J. Syst. Evol. Microbiol., 2018 Dec; 68 (12): 3741 -46-
OPPOSITION- Stecher et al, PLoS Pathogens, 2011; 6 (1): e1000711-
OPPOSITION- Sze et al, mBio, 2016 Aug 23; 7 (4): e01018-16-
OPPOSITION- Udayappan, S. et al. (2016) ‘Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice’, npj Biofilms and Microbiomes. Nature Publishing Group, 2(May). doi:10.1038/npjbiofilms.2016.9-
OPPOSITION- van Baarlen, P. et al. Differential NF-kB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. PNAS, 2009; 106(7); 2371-2376-
OPPOSITION- Vital and Tiedje Revealing the Bacterial Butyrate Synthesis pathways by Analyzing (Meta)genomic Data. mBio. 2014 Mar-Apr; 5(2): e00889-14-
OPPOSITION- Vrieze, A. et al. The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia, 2010; 53: 606-613-
OPPOSITION- Wang et a 1(2016) Molecular Medicine Reports 14:3293-3300-
OPPOSITION- Zoetendal et al, ISME J, 2012; 6: 1415-1426-
OPPOSITION- RAJILIC-STOJANOVIC et al., "Diversity of the human gastrointestinal tract microbiota revisited", Environ. Microbiol., (20070000), vol. 9, no. 9, pages 2125 - 2136, XP055631751
OPPOSITION- MUNOZ-TAMAYO et al., "Kinetic modelling of lactate utilization and butyrate production by key human colonic bacterial species", FEMS Microbiol. Ecol., (20110000), vol. 76, pages 615 - 624, XP055310779
OPPOSITION- SANZ et al., "Insights into the roles of gut microbes in obesity", Interdisciplinary Perspectives on Infectious Diseases, (20080000), pages 1 - 9, XP002726152
OPPOSITION- CANANI et al., "Potential beneficial effects of butyrate in intestinal and extraintestinal diseases", World J. Gastroenterol., (20110328), vol. 17, no. 12, pages 1519 - 1528, XP055540843

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents